Fermedics Secures Exclusive Distribution Rights for ProAntro® in Key European Territories

Back to overview

Fermedics is thrilled to announce that it has obtained exclusive distribution rights for ProAntro® from Golden Biotechnology Corporation. This exclusive agreement covers strategic European territories, including the Benelux region, DACH region, France and Italy.

About ProAntro®: Unlocking the Potential of Antrodia Camphorata

ProAntro® is a revolutionary ingredient derived from Antrodia Camphorata, a unique functional mushroom cultivated through patented solid-state fermentation. This targeted fermentation process ensures an optimal concentration of bioactive substances such as triterpenoids, polysaccharides, superoxide dismutase (SOD) and nucleic acids. This exclusive and protected fermentation process also ensure no pollutants, contaminants and toxin will enter into the product. The bioactive ingredients in ProAntro® has been extensively studied and has demonstrated activities in liver protection, anti-inflammation, neuroprotection and other health benefits.

Key features of ProAntro® include:

  • ProAntro® is approved by EFSA for use as a novel food ingredients in food supplements.
  • First available Antrodia camphorata mycelium powder on the European market.
  • Clinical Backing: ProAntro® boasts two proprietary human clinical studies supporting its efficacy in preventing Alcoholic Fatty Liver Disease (AFLD) and mitigating the effects of alcohol consumption.
  • Safety Assurance: Rigorous safety and toxicology studies have been completed and the production protocol adheres to pharmaceutical-level quality control testing, ensuring the highest safety standards.
  • Liver Health Benefits: v offers a full-spectrum impact on liver health, including prevention of NAFLD (Non-Alcoholic Fatty Liver Disease) and liver cirrhosis, reduction of adverse effects after alcohol consumption, and improvement of various blood markers associated with liver function.

About Fermedics: Pioneering Premium Fermented Botanical Ingredients

Fermedics is at the forefront of developing premium fermented botanical ingredients, with a focus on enhancing bioavailability, bioactivity, and efficacy through targeted fermentation. The company’s portfolio includes fully metabolized fermented herbal extracts, prebiotics, postbiotics and various nutrients for nutraceutical formulations in consumer healthcare. Committed to quality, safety and efficacy, Fermedics combines scientific innovation with traditional techniques.

To learn more about Fermedics and its innovative offerings, please visit www.fermedics.com

About Golden Biotechnology Corporation: Driving Innovation in Medicinal Fungus Research

Golden Biotechnology Corporation is an innovative biotechnology company based in Taipei with a proven track record in developing Antrodia Camphorata based products. For the past 20 years, the company have been actively researching and conducting numerous studies to evaluate the efficacy, safety and new uses for Antrodia Camphorata. ProAntro® is the results of the dedication and single-mindedness pursuit to introduce the best Antrodia Camphorata in the market that is fully supported by clinical studies. Golden Biotech only uses the solid-state fermentation method to produce the highest quality Antrodia Camphorata which is available exclusively in ProAntro®.

For more information, please visit the website.

For inquiries or more information about this exclusive distribution agreement and ProAntro®, please contact Fermedics to explore collaboration opportunities.


Share this post